Figures computed from official regulatory filings — .
Ownershipinsiders 71.62% · institutions 8.88%
In EUR · as of Nov 2, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Drägerwerk AG & Co. KGaA only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas measurement technology, and comprehensive risk management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. In addition, it offers patient monitoring systems; anaesthesia machines; medical ventilators and lung monitoring; neonatal incubators and thermoregulation; phototherapy lights and bilirubinometers; surgical and examination lights; medical pendants and infrastructure design; medical gas pipeline system in hospitals; and hospital consumables and accessories, as well as hospital planning and design services. Further, the company offers alcohol and drug testing; diving equipment; fixed gas detectors; hazmat suits; portable gas detection; head and eye protection; rescue and escape; respiratory protection; safety-training systems; thermal imaging cameras; and workshop solution and breathing gas supply, as well as provides various training and services. The company was founded in 1889 and is headquartered in Lübeck, Germany. Drägerwerk AG & Co. KGaA operates as a subsidiary of Dr. Heinrich Dräger GmbH.
Market information source · Nov 2, 2026
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Dr. Heinrich Dräger GmbH | Buy | $383K | conv 35First in 12mo | BAFIN | |
| Dr. Heinrich Dräger GmbH | Buy | Value needs reviewn/a (Value under review) | First in 12mo | BAFIN |